A new risk of anaphylaxis.
Brams
R F
RF
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy; D004837:Epinephrine / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D004837:Epinephrine